Savant Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22,888	Closed	-$1.27M	–	1493
2024 Q3	$1.27M	Buy	+22,888	New	+$1.27M	0.01%	561
2024 Q2	–	Sell	-7,245	Closed	-$338K	–	1322
2024 Q1	$338K	Buy	+7,245	New	+$338K	﹤0.01%	860